Concepedia

Real-world 2-year outcome of atrial fibrillation treatment with dabigatran, apixaban, and rivaroxaban in patients with and without chronic kidney disease

Cosmo Godino, Francesco Melillo, Francesca Rubino, Luca Arrigoni, Alberto Cappelletti, Patrizio Mazzone, Paolo Mattiello, Paolo Della Bella, Antonio Colombo, Anna Salerno,

Internal and Emergency Medicine · 2019 · 26 citations · 37 references

DOI

Concepts

References

37

Dabigatran versus Warfarin in Patients with Atrial Fibrillation

Stuart J. Connolly, Michael D. Ezekowitz, Salim Yusuf et al. · New England Journal of Medicine · 2009 · 11.2K citations · Full text

, , +12

Practical Nonparametric Statistics

David J. Groggel, W. J. Conover · Technometrics · 2000 · 11.1K citations

, , +13

Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation

Manesh R. Patel, Kenneth W. Mahaffey, Jyotsna Garg et al. · New England Journal of Medicine · 2011 · 9.4K citations · Full text

, , +15

Apixaban versus Warfarin in Patients with Atrial Fibrillation

Christopher B. Granger, John H. Alexander, John J.V. McMurray et al. · New England Journal of Medicine · 2011 · 8.9K citations · Full text

, , +11

2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS

Paulus Kirchhof, Stefano Benussi, Dipak Kotecha et al. · EP Europace · 2016 · 6.5K citations · Full text

, , +16